<seo title="Davita Inc." metakeywords="davita publicly traded,davita medical group,financial performance davita,management davita" metadescription="Davita Inc. is a leading provider of kidney care services in the United States." />
===Introduction to Davita Inc.===

Davita Inc. is a leading provider of kidney care services in the United States. The company operates over 2,400 dialysis centers in the United States and provides services to over 200,000 patients. Davita Inc. is a publicly traded company on the New York Stock Exchange (NYSE) under the ticker symbol DVA. The company was founded in 1999 and is headquartered in Denver, Colorado.
===History of Davita Inc.===

Davita Inc. was founded in 1999 by Kent Thiry and his partners. The company was initially known as Total Renal Care, Inc. and was focused on providing dialysis services to patients with end-stage renal disease. In 2006, the company changed its name to Davita Inc. and began to expand its services to include chronic kidney disease management, transplant services, and home dialysis. In 2012, Davita Inc. acquired DaVita Medical Group, a physician network, and in 2013, the company acquired HealthCare Partners, a physician network and medical group.
===Financial Performance of Davita Inc.===

Davita Inc. has seen strong [[Financial Performance|financial performance]] over the past few years. In 2019, the company reported total revenues of $13.3 billion, an increase of 8.3% from the previous year. [[Net Income|Net income]] for the year was $1.2 billion, an increase of 8.7% from the previous year. The company’s stock price has also seen strong performance, with the stock price increasing from $50.00 per share in January 2019 to $90.00 per share in December 2019.
===Management of Davita Inc.===

Davita Inc. is led by CEO Javier Rodriguez, who has been with the company since 2011. The company’s [[Board Of Directors|board of directors]] is composed of nine members, including Kent Thiry, the company’s founder and chairman. The board of directors is responsible for overseeing the company’s operations and ensuring that the company is meeting its financial and operational goals.
===Conclusion===

Davita Inc. is a leading provider of kidney care services in the United States. The company has seen strong financial performance over the past few years and is led by a strong management team. The company’s stock price has also seen strong performance, with the stock price increasing from $50.00 per share in January 2019 to $90.00 per share in December 2019. With its strong financial performance and experienced management team, Davita Inc. is well-positioned to continue to be a leader in the kidney care industry